These success, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two assist the thought of focusing on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-co